The case study focuses on a Natural History Study Aparito undertook for patients with Late Onset GM2 using digital health technology (including a wearable device and smartphone
apps with mobile PROs) with continuous, remote monitoring and real time capture of
symptoms and disease impact as perceived by the patients.
